|Application ||IHC-P, E|
|Clone Names||8003 (99/12)|
|Purification||Purified IgG prepared by affinity chromatography on Protein A|
|Immunogen||Purified human pepsinogen 1.|
|Shelf Life||18 months from date of despatch.|
|Target/Specificity||Mouse anti-Human pepsinogen 1 antibody, clone 8003 recognizes human Pepsinogen I, a zymogen or proenzyme secreted by chief cells in the stomach. It is cleaved to form pepsin both in an autocatalytic fashion and by pepsin itself. In humans there are two related forms of pepsin, Pepsinogen I (also known as pepsinogen A), and Pepsinogen II (also known as Pepsinogen B or progastricsin).Mouse anti-Human pepsinogen 1 antibody, clone 8003 has an affinity of 4 x 1010 l/mol human Pepsinogen I.|
|Preservative & Stabilisers||0.09% Sodium Azide (NaN3)|
|Storage||Store at +4℃ or at -20 ℃.|
|Precautions||Anti-Human Pepsinogen I Antibody, clone 8003 (99/12) is for research use only and not for use in diagnostic or therapeutic procedures.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
1. Ueyama, H. et al. (2010) Gastric adenocarcinoma of fundic gland type (chief cell predominant type): proposal for a new entity of gastric adenocarcinoma.Am J Surg Pathol. 34: 609-19. 2. Genta, R.M. & Pusztaszeri, M. (2006) The gastric mucosa in gastric cancer patients in a low-incidence area.Eur J Gastroenterol Hepatol. 18 (10): 1085-93. 3. Fujita Y et al. (2015) Incidence of lymphatic involvement in differentiated-type intramucosal gastric cancers as examined by endoscopic resection.Gastric Cancer. Feb 1. [Epub ahead of print] 4. Hidaka, Y. et al. (2013) Alteration in the Wnt/ß-catenin signaling pathway in gastric neoplasias of fundic gland (chief cell predominant) typeHum Pathol. 44: 2438-48. 5. Sakamoto, H. et al. (2011) Cell lineage dynamics in the process leading to intestinal metaplasia.J Gastroenterol. 46: 620-8.
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at firstname.lastname@example.org.